Fate Therapeutics, Inc. · NASDAQ:FATE
Goldman Sachs Group Inc reported a 7.40% stake in Fate Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 9, 2025
Goldman Sachs Group Inc reported a 7.40% stake in Fate Therapeutics, Inc., 8,487,220 shares, as a passive investor on Mar 31, 2025. Filed May 9, 2025 (Schedule 13G).
- Stake
- 7.40%
- Shares
- 8,487,220
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 7.40% | 8,487,220 |
| GOLDMAN SACHS & CO. LLC | 7.40% | 8,487,220 |
Source
Related
- Fate Therapeutics, Inc.
- Goldman Sachs Group Inc
- Fate Therapeutics, Inc. shareholders
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 14, 2025
- Form 4 · Tahl Cindy · Aug 5, 2026
- Form 4 · Valamehr Bahram · Aug 5, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 8, 2026
- Form 4 · Tahl Cindy · May 21, 2026
- Form 4 · Valamehr Bahram · May 21, 2026